The U.S. Special Senate Committee on Aging begins a hearing on rising drug costs on Wednesday that will focus on the practices of companies such as Quebec-based Valeant and U.S.-based Turing Pharmaceuticals.
Source:CBC | Business News http://ift.tt/1NbJYv7
0 commentaires:
Enregistrer un commentaire